TrialMatch

Sign in Sign up Create account

Search the registry

Find clinical trials

Searching 2,585 mirrored studies from ClinicalTrials.gov. Create a profile to see personalised match scores.

Filters

Clear all

2,585 studies found

Sort by

Recruiting

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Phase 1 · 1 site

Compare

Recruiting

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Phase 1 · 20 sites

Compare

Recruiting

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Phase 1 / Phase 2 · 3 sites

Compare

Recruiting

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Phase 2 · 7 sites

Compare

Recruiting

Ziftomenib Maintenance Post Allo-HCT

Phase 1 · 2 sites

Compare

Recruiting

Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Phase 1 / Phase 2 · 1 site

Compare

Recruiting

First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)

Phase 1 · 6 sites

Compare

Recruiting

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Phase 2 / Phase 3 · 73 sites

Compare

Recruiting

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Phase 1 / Phase 2 · 71 sites

Compare

Recruiting

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Phase 3 · 190 sites

Compare

Recruiting

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Phase 1 / Phase 2 · 45 sites

Compare

Recruiting

Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)

1 site

Compare

Potential match only. Final eligibility is determined by the study team.